KELLY CALKINS: Open Payments
NPI 1689823718 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 33 payments from 8 companies in 2025. Trend: 2023 $319 · 2024 $532 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $194 |
| Amgen Inc. | 11 | $162 |
| ABBVIE INC. | 1 | $91 |
| Novo Nordisk Inc | 4 | $86 |
| PFIZER INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $43 |
| Exact Sciences Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: AIRSUPRA, VRAYLAR, EVENITY, OTEZLA, FARXIGA, Wegovy, MOUNJARO, Ozempic.
Industry payments across CA — which companies pay providers there.
